Peripartum Exposure to Biologic Therapy Does Not Impact Postpartum Wound Healing in Women With IBD

Inflammatory Bowel Disease (IBD) in Pregnancy Clinical Care Pathway – A Report from the American Gastroenterological Association IBD Parenthood Project Working Group

(2019) Uma Mahadevan et al.   GASTROENTEROLOGY

Systematic review with meta-analysis: risk of post-operative complications associated with pre-operative exposure to anti-tumour necrosis factor agents for Crohn’s disease

(2019) Yang-Sheng Lin et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

415a – Anti-Tumor Necrosis Factor Therapy is Not Associated with Post-Operative Infection: Results from Prospective Cohort of Ulcerative Colitis and Crohn's Disease Patients Undergoing Surgery to Identify Risk Factors for Postoperative Infection I (Puccini)

(2019) Benjamin L. Cohen et al.   GASTROENTEROLOGY

Risk of post-operative surgical site infections after vedolizumab vs anti-tumour necrosis factor therapy: a propensity score matching analysis in inflammatory bowel disease

(2018) K. T. Park et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Postpartum infection in relation to maternal characteristics, obstetric interventions and complications

(2018) Daniel Axelsson et al.   JOURNAL OF PERINATAL MEDICINE

Management of inflammatory bowel disease in pregnancy

(2013) Susie W Ng et al.   Expert Review of Clinical Immunology

Inflammatory bowel disease: risk factors for adverse pregnancy outcome and the impact of maternal weight gain

(2012) Galia Oron et al.   Journal of Maternal-Fetal & Neonatal Medicine

Outcomes of Obstetric Hospitalizations Among Women With Inflammatory Bowel Disease in the United States

(2008) Geoffrey C. Nguyen et al.   Clinical Gastroenterology and Hepatology